Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 1, 2018

View Archived Issues

Fusion of neoplastic cells with macrophages confers metastatic growth advantages and poor prognosis

Bispecific-anchored cytotoxicity activator antibody induces ovarian cancer cell death

Ability to analyze old samples leads to new ovarian cancer biomarker

Atlantic Healthcare reports phase I data on oral alicaforsen for Crohn's disease

Sanwa Kagaku Kenkyusho obtains approval for Metoana in Japan

FDA gives favorable response to pre-IND meeting package for phase II study of CSTD002-NK

NO signals quorum for macrophages

Combination antibodies suppress HIV and resistance

Exhausted T cells play role in fibrosis

Cell cycle kinase affects platelet cytoskeleton

Korea Research Institute of Chemical Technology and collaborators patent GPR119 agonists

Sunshine Lake Pharma describes new SLC22A12 and xanthine oxidase inhibitors

Lytix Biopharma initiates recruitment in the sarcoma study of LTX-315

New PRMT5 inhibitors discovered at Prelude Therapeutics

FDA approves IND application to initiate clinical testing of TT-00420 in TNBC

Eli Lilly presents nuclear receptor ROR-gammaT inverse agonists

Achillion Pharmaceuticals identifies complement factor D inhibitors

BIT225-009 phase II study demonstrates significant immunological benefits in HIV-infected patients

FDA approves Fycompa for partial-onset seizures in pediatric patients

Promising outcome of IDMC interim review for phase II study of F-351 for liver fibrosis

FDA approves Libtayo for cutaneous squamous cell carcinoma

Innovent cleared to conduct clinical trials of IBI-188

FDA grants accelerated approval to Arikayce for MAC lung disease

AvroBio updates gene therapy programs in Gaucher's disease and Fabry disease

VEGF-D, MMP-2 and MMP-7 biomarkers in lymphangioleiomyomatosis and tuberous sclerosis complex

CaSR found as a novel therapeutic target for pulmonary fibrosis

NEAT1 found as new therapeutic target for occlusive vascular diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...